Showing results (1111-1120 of 2,445) with videos related to

Sort By:
Pageof 245
Clinical and Translational Science|March 21, 2024
The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteersStefan J Jodl, Wouter Ten Voorde, Stefan Klein, et al.
Clinical and Translational Science|March 21, 2024
The impact of skin color and tone on histamine iontophoresis and Doppler flowmetry measurements as a pharmacodynamic biomarkerAarya Ramprasad, Adara Ezekwe, Brian R Lee, et al.
Clinical and Translational Science|October 2, 2024
Association between statin use and dry eye disease in patients with hyperlipidemia: A population-based retrospective cohort studyYong-Wei Wang, Sian-De Liu, Guan-Ling Lin, et al.
Clinical and Translational Science|September 30, 2024
Mass balance and pharmacokinetic characterization of zavegepant in healthy male subjectsRajinder Bhardwaj, Mary Donohue, Jennifer Madonia, et al.
Clinical and Translational Science|September 18, 2024
Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitisNabila Ibnou Zekri Lassout, Vishal Goyal, Edrich Krantz, et al.
Clinical and Translational Science|October 1, 2024
Pharmacokinetic model-guided enoxaparin dosing in the Neonatal ICU: Retrospective cohort study to plan for prospective feasibility trialHaden Bunn, Catherine Schentag, Leonardo R Brandão, et al.
Clinical and Translational Science|March 4, 2024
Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjectsHeejae Won, Deok Yong Yoon, Sangmi Lee, et al.
Clinical and Translational Science|February 27, 2024
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinomaPing Hu, Haiqing Isaac Dai, James Bourdage, et al.
Clinical and Translational Science|February 16, 2024
Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumorsDebbie Robbrecht, Jean-Jacques Grob, Oliver Bechter, et al.
Clinical and Translational Science|November 22, 2023
Developing a mechanistic translational PK/PD model for a trifunctional NK cell engager to predict the first-in-human dose for acute myeloid leukemiaSiak-Leng Choi, Delphine Valente, Angela Virone-Oddos, et al.
Pageof 245